Nancy Pelosi
Congress Won’t Stop Trading Stocks
Researchers studying congressional stock ownership have found that the practice has effects on lobbying activity and potentially on market movements.
Categories
Pharma Companies Spend Billions More on Stock Buybacks Than Developing Drugs, House Report Finds
The largest drugmakers spent $56 billion more on stock buybacks and dividends than on research and development from 2016 to 2020, according to a new House committee report.
Categories
Infrastructure Month in Congress, For Real, This Time, Maybe
Democrats have given themselves just a few weeks to pass a preliminary budget resolution for one of two infrastructure bills moving in tandem.
Categories
Groups Call on Congress: Fund Your Staff
The average Hill staffer stays for only about three years, with many moving to become lobbyists.
Categories